Regulator of G-protein signaling (RGS) proteins accelerate GTP hydrolysis by heterotrimeric G-protein a subunits and thus inhibit signaling by many G protein-coupled receptors. Several RGS proteins have a multidomain architecture that adds further complexity to their roles in cell signaling in addition to their GTPase-accelerating activity. RGS12 contains a tandem repeat of Ras-binding domains but, to date, the role of this protein in Ras-mediated signal transduction has not been reported. Here, we show that RGS12 associates with the nerve growth factor (NGF) receptor tyrosine kinase TrkA, activated H-Ras, B-Raf, and MEK2 and facilitates their coordinated signaling to prolonged ERK activation. RGS12 is required for NGFmediated neurite outgrowth of PC12 cells, but not outgrowth stimulated by basic fibroblast growth factor. siRNA-mediated knockdown of RGS12 expression also inhibits NGF-induced axonal growth in dissociated cultures of primary dorsal root ganglia neurons. These data suggest that RGS12 may play a critical, and receptorselective, role in coordinating Ras-dependent signals that are required for promoting and/or maintaining neuronal differentiation.
Introduction
Extracellular stimuli such as neurotransmitters, hormones, odorants and light are recognized by G protein-coupled receptors (GPCRs), one of the most abundant and diverse protein families in the nervous system (Davies et al, 2002b) . Intercellular communication via G-protein-mediated signaling pathways in the nervous system is crucial for normal brain development and regulation of adult neural processes (Davies et al, 2002b) . Thus, defining the molecular determinants that control GPCR signaling is important to understanding normal development and physiology of the nervous system and the pathophysiology of nervous systemrelated disorders.
One level of regulation of GPCR signaling is mediated by 'regulators of G-protein signaling' (RGS) proteins that accelerate Ga GTP hydrolysis and inhibit signaling by many GPCRs (Ross and Wilkie, 2000) . For example, mice lacking RGS9 show enhanced responses to photonic stimulation and morphine administration, suggesting that RGS9 is a potent negative regulator of both rhodopsin and opioid receptor signal transduction in vivo (Chen et al, 2000; Zachariou et al, 2003) . In general, however, contributions by RGS proteins to physiological control of specific receptor signaling cascades are only now being elucidated. Multidomain RGS proteins add further complexity to the potential signaling roles played by RGS proteins in addition to their GTPaseaccelerating activity (reviewed in Ross and Wilkie, 2000; Siderovski and Willard, 2005) .
RGS12 is an example of a multidomain RGS protein with numerous signaling regulatory elements. In addition to a central RGS domain, RGS12 contains a PDZ (PSD-95/Discslarge/ZO-1 homology) domain, a phosphotyrosine-binding (PTB) domain, tandem Ras-binding domains (RBDs), and a GoLoco (Ga i/o -Loco) interaction motif (Ponting, 1999; Siderovski et al, 1999) . The PTB domain recruits RGS12 in a phosphotyrosine-dependent manner to the SNARE-binding region of the Ca v 2.2 calcium channel (Richman et al, 2005) , thereby determining the rate of desensitization of GABA B receptor-mediated calcium current inhibition in dorsal root ganglia (DRG) neurons (Schiff et al, 2000) . Little is known about the in vivo function of other domains within mammalian RGS12. Recently, we examined RGS12 expression patterns during mouse development. Full-length RGS12 is expressed predominantly in trigeminal and DRG neurons and muscle in the E14.5 embryonic mouse (Martin-McCaffrey et al, 2005) , suggesting a role for mammalian RGS12 in myo-and neurogenesis.
Loco, the Drosophila RGS12 ortholog, is essential for multiple processes in fly development, including dorsal/ ventral axis formation, neuroblast asymmetric cell division, and nurse cell dumping (Pathirana et al, 2001; Yu et al, 2005) . loco is expressed in lateral glial cells in the developing embryonic central nervous system and required for correct glial cell differentiation (Granderath et al, 1999) . Normal glial-glial cell contacts are absent in loco-deficient flies, resulting in a loss of the blood-brain barrier and subsequent gross locomotor defects in surviving mutants. Recently, Loco, the GPCR Moody, and the Ga subunits Gai and Gao were found to be expressed in surface glia; these four proteins are thought to act as part of a common signaling pathway critical for blood-brain barrier formation Schwabe et al, 2005) .
The requirement for Loco in glial cell development and normal locomotion suggests that mammalian RGS12 may also play a critical role in glial cell differentiation. Here, we demonstrate that RGS12 facilitates formation of a Ras/ Raf/MEK/ERK multiprotein complex, suggesting a function as a scaffold for the extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) cascade. Furthermore, RGS12 interacts with the nerve growth factor (NGF) receptor TrkA, and small interfering RNA (siRNA)-mediated downregulation of endogenous RGS12 selectively inhibits NGF-induced neuritogenesis of PC12 cells and axonal growth of embryonic DRG neurons. These results suggest that RGS12 may function in promoting a differentiated phenotype by organizing a TrkA, Ras, Raf, MEK, and ERK signal transduction complex in vivo.
Results

RGS12 interacts with MAPK cascade components
Beyond two Ga i interaction domains (an RGS domain and a C-terminal GoLoco motif), RGS12 has additional protein motifs found in signaling adaptors, scaffolds, and effectors ( Figure 1A ): N-terminal PDZ and PTB domains and a tandem repeat of RBDs (Snow et al, 1998; Schiff et al, 2000; Kimple et al, 2001) . To identify additional RGS12 interactors, yeast two-hybrid screens of mouse embryo and brain cDNA libraries were performed using the PDZ/PTB domains and an internal span including the RGS domain and tandem RBDs ( Figure 1A ). Two interactors from the mouse brain library were obtained with the N-terminal bait and validated as bait specific (Supplementary Figure S1 ): the C-terminal tail of mouse SAPAP3 (Welch et al, 2004 ) and the C-terminal tail of MEK2, a middle-tier protein kinase (MAP2K) within the ERK cascade (Johnson and Lapadat, 2002) .
Both SAPAP3 and MEK2 end in canonical class I PDZbinding targets (SAPAP3: -Q-T-R-L-COOH; MEK2: -R-T-A-V-COOH), suggesting that both interactors bind the PDZ domain. The RGS12 PDZ domain is known to recognize class I PDZ-binding targets ending in Thr-x-[Leu/Val]-COOH (Snow et al, 1998) . Biosensor studies indicated that the final 16 amino-acids (aa) of MEK2 were sufficient to bind directly to the RGS12 PDZ domain in vitro (Supplementary Figure  S2) . The interaction with MEK2 was specific for the PDZ domain of RGS12, as co-immunoprecipitation was only seen between full-length MEK2 and protein fragments containing the RGS12 PDZ domain ( Figure 1B) ; neither the first PDZ domain of the Drosophila scaffold InaD nor the PTB domain of mouse Numb were capable of co-immunoprecipitating MEK2. RGS12 selectively interacts with MEK2, and not other MAP2K members, in cell co-immunoprecipitations (data not shown).
A separate yeast two-hybrid screen using a fragment from the RGS domain to the second RBD (Supplementary Figure  S1) identified a fragment of A-Raf (aa 36-153) that spans the RBD and cysteine-rich C1 (or 'CRD') domains N-terminal to its kinase domain (Huleihel et al, 1986) . Subsequent coimmunoprecipitation studies showed that full-length A-Raf and B-Raf ( Figure 1C and D) , but not c-Raf-1 (Supplementary Figure S3) , associate with RGS12; indeed, the interaction with B-Raf is observed upon expressing a minimal RGS12 fragment containing solely the tandem RBDs ( Figure 1D ). Similar to A-Raf, residues within the B-Raf N-terminus appear to mediate binding to RGS12, as B-Raf fragments spanning the first 374 aa efficiently co-immunoprecipitated with full-length RGS12 (Supplementary Figure S4) .
RGS12 preferentially binds to activated H-Ras
Association of RGS12 with Raf and MEK (two tiers of the Rasregulated ERK cascade), coupled with the presence of two RBDs within RGS12, led us to test whether RGS12 also interacts directly with Ras GTPases. RBDs are found in Ras effector proteins such as RalGDS, phosphoinositide-3 0 kinase, and the Raf kinases that bind preferentially to activated Ras GTPases . Upon screening several Ras family members, we found that RGS12 preferentially coimmunoprecipitates with H-Ras and not K-, M-, or R-Ras. This interaction was specific to activated H-Ras (Figure 2A and B) . In some instances, we observed binding of RGS12 to activated N-Ras ( Figure 2A) ; however, when detected, this interaction was substantially weaker than that observed with H-Ras. Association between RGS12 and active H-Ras appears to be mediated by the tandem RBD region of RGS12 ( Figure 2C ). Interaction with activated H-Ras is diminished by point mutation of histidine-995, within the first RBD of RGS12, to leucine ( Figure 2D ; H995L), a position analogous to the loss-of-function R89L mutation that abrogates c-Raf-1 binding to H-Ras (Fabian et al, 1994) (Supplementary Figure  S5) . However, mutation of H995 in RGS12 does not interfere with its interaction with B-Raf ( Figure 2E ), suggesting that the RGS12(H995L) variant is properly folded. The RGS12 paralog RGS14 is reported to interact with Rap GTPase isoforms (Traver et al, 2004; Kiel et al, 2005; Mittal and Linder, 2006) ; however, no interaction of RGS12 with Rap1A, Rap1B, or Rap2B was observed in cell co-immunoprecipitations (Supplementary Figure S6) .
RGS12 coordinates and enhances signaling to ERK activation
Interactions with activated H-Ras and the first two tiers of the Ras-regulated ERK signaling cascade suggests a role for RGS12 as a MAPK scaffold facilitating receptor signaling to ERK activation. We previously showed that RGS12 associates with the PDGFb receptor in an agonist-independent manner (Sambi et al, 2006) ; thus, we measured endogenous PDGFbR signaling in CHO-K1 cells (Maudsley et al, 2000) in the presence of increasing RGS12 levels. RGS12 expression modulated PDGF-BB-stimulated activation of ERK2 phosphorylation in a concentration-dependent, biphasic manner ( Figure 3A )-namely, an increase in phospho-ERK2 levels upon low RGS12 expression, transitioning to a decrease to phospho-ERK2 levels upon higher RGS12 expression. These results are reminiscent of 'combinatorial inhibition', a hallmark of signaling scaffolds that arises because at low scaffold concentrations, signaling components are in excess and formation of a functional complex is likely to occur, but when scaffold is in excess, non-functional complexes with less than the full complement of components become more prevalent (Bray and Lay, 1997; Levchenko et al, 2000) . This biphasic effect of RGS12 expression was selective for PDGFbR signaling in CHO-K1 cells, as no inhibition of epidermal growth factor (EGF)-mediated ERK2 activation was seen even at the highest RGS12 expression levels (data not shown).
To investigate the interaction of RGS12 with multiple Ras/ MAPK signaling components, we coexpressed RGS12 and activated Ras GTPases with Raf kinase isoforms A-Raf, B-Raf, or c-Raf-1, and examined the ability of RGS12 to bind to Ras. RGS12 does not interact with activated R-Ras ( Figure 2A) ; however, activated H-Ras and R-Ras both interact with all three Raf isoforms (reviewed in Wittinghofer and Herrmann, 1995) . Activated R-Ras did not co-immunoprecipitate with RGS12 in the absence or presence of any of the three Raf kinases ( Figure 3B ). In contrast, the amount of HRas bound to RGS12 increased upon concomitant expression of B-Raf, but not A-Raf or c-Raf-1 ( Figure 3B ), suggesting that these binary interactions (H-Ras/RGS12, RGS12/B-Raf, and H-Ras/B-Raf) are mutually supportive and/or a trimeric complex of all three proteins exists.
In addition to H-Ras and B-Raf, RGS12 interacts with MEK2 ( Figure 1) ; thus, we examined whether a complex of all four proteins might assemble in cells. Activated H-Ras (G12V mutant), B-Raf, and MEK2 were each detected in RGS12 immunoprecipitates upon coexpression ( Figure 3C and D). Simultaneous expression of MEK2 with either activated HRas or B-Raf had no effect on the amount of H-Ras or B-Raf that co-immunoprecipitated with RGS12 ( Figure 3C ). In contrast, coexpression of activated H-Ras enhanced the amount of both B-Raf and MEK2 associating with RGS12 ( Figure 3C ). Amounts of co-immunoprecipitating H-Ras, B-Raf, and MEK2 were additionally enhanced when all four proteins were simultaneously coexpressed in HEK 293T cells (Figure 3C and D). These results suggest that the binding of activated H-Ras to RGS12 facilitates the assembly of a multiprotein complex on RGS12 that functionally links H-Ras with the first two tiers of the MAPK cascade (B-Raf and MEK2). Several MAPK scaffold proteins (e.g. KSR, MP1, b-arrestin-2; reviewed in Kolch, 2005 ) also form macromolecular complexes with the third-tier kinase ERK. As RGS12 interacts with activated H-Ras, B-Raf, and MEK2, we reasoned that RGS12 may also assemble a MAPK complex containing the third-tier kinase. An interaction between RGS12 and ERK1 was not observed when only those two proteins were coexpressed in HEK 293T cells ( Figure 3D ); however, when activated H-Ras, B-Raf, and MEK2 were also coexpressed, ERK1 co-immunoprecipitated with RGS12 ( Figure 3D ). These findings further support the hypothesis that RGS12 acts as a scaffold to assemble multiple components of the Ras-activated MAPK cascade.
Loss of RGS12 inhibits NGF-mediated and MAPK cascade-dependent neuritogenesis
To define the role of RGS12 as a cellular MAPK scaffold, we identified cell lines that express RGS12 endogenously. Rabbit antisera against both the N-terminus and RGS domain of RGS12 confirmed the expression of full-length RGS12 in PC12 rat pheochromocytoma cells (Supplementary Figure S7) . RGS12 co-immunoprecipitated with both endogenous H-Ras and B-Raf in PC12 cells ( Figure 4A ), but not with Rap1, suggesting that a complex of RGS12 with specific MAPK pathway members exists between endogenous components in PC12 cells.
NGF stimulation of the TrkA receptor causes terminal differentiation, growth inhibition, and neurite formation in PC12 cells (Altin et al, 1991; Ng and Shooter, 1993) . NGF induces rapid and sustained activation of both Ras and ERK, and inhibition of either Ras or ERK blocks neurite induction (Cowley et al, 1994) . Thus, NGF-induced neurite formation is mediated by Ras activation of the ERK MAPK cascade. To address a possible role for RGS12 in NGF-induced neurite formation, we employed siRNA to suppress endogenous RGS12 expression. A pool of four duplexes efficiently reduced RGS12 expression (Supplementary Figure S8) ; upon separation, each of the four siRNA oligonucleotides also reduced expression of RGS12 ( Figure 4C inset and Supplementary Figure S8 ). RNAi suppression of RGS12 expression impaired NGF-mediated neurite formation ( Figure 4B and Supplementary Figure S9 ), reducing the average length of NGFpromoted neurites over 48 h compared with cells transfected with non-specific siRNA ( Figure 4C ). These results suggest FLAG-Raf: To establish whether the identified interaction partners of RGS12 are also essential for NGF-mediated neurite outgrowth, we employed siRNA to suppress endogenous A-Raf, B-Raf, and MEK2 levels ( Figure 4D ). Knockdown of B-Raf and MEK2 resulted in reduced PC12 neuritogenesis upon NGF treatment, similar to that of RGS12 knockdown ( Figure 4E) ; in contrast, knockdown of A-Raf did not alter average neurite length promoted by NGF treatment. These results support the hypothesis that RGS12 and its MAPK-cascade-binding partners B-Raf and MEK2 participate in NGF-mediated neuritogenesis and suggest that the scaffolding function of RGS12 may be important in this process.
To establish further the role of RGS12 in MAPK cascadedependent neuritogenesis, we examined the effect of RGS12 knockdown on PC12 neurite outgrowth stimulated by activated mutants of H-Ras (G12V; Taparowsky et al, 1982) and B-Raf (V600E; Davies et al, 2002a) . Knockdown of RGS12 impaired both H-Ras-and B-Raf-stimulated neurite formation ( Figure 4F and G), suggesting that RGS12 is an effector and scaffold for activated H-Ras and B-Raf in PC12 cells. 1993) . EGF acting through the EGF receptor induces transient activation of ERK, resulting in proliferation (Huff et al, 1981; Marshall, 1995) . In contrast, NGF acting through the TrkA receptor induces both transient and prolonged phosphorylation of ERK, with the prolonged activation required for differentiation (Qui and Green, 1992; Traverse et al, 1992) . We thus examined the effect of RGS12 knockdown on ERK activation kinetics in PC12 cells stimulated with NGF and EGF. Knockdown of RGS12 did not change the levels of transient ERK activation (5-10 min) by NGF ( Figure 5A ) or EGF (data not shown). However, the duration of ERK activation upon NGF treatment was shortened by RGS12 knockdown (Figure 5A ), suggesting a mechanistic explanation for the impairment in NGF-mediated neuritogenesis seen upon RGS12 depletion (Figure 4) . Knockdown of B-Raf and MEK2 levels, but not A-Raf levels, also leads to a reduction in sustained ERK activation (e.g. Figure 5B ; 120 min post-NGF treatment). Subcellular localization of MAPK scaffolds, and the proteins that they coordinate, is critical for their function (Teis et al, 2002) . We previously established that epitopetagged RGS12 localizes to intracellular puncta in primary guinea-pig airway smooth muscle cells and regulates PDGFbR trafficking and PDGF-mediated activation of the MAPK cascade (Sambi et al, 2006) . Similarly, in PC12 cells, a YFP fusion of RGS12 localizes to punctate structures, in comparison with YFP alone ( Figure 5C ). To determine whether these puncta were endocytic vesicles, we stained with early endosomal and late endosomal markers, EEA1 and LAMP1, respectively (Fukuda, 1991; Christoforidis et al, 1999) . RGS12-YFP showed colocalization with EEA1 ( Figure 5D ) as well as with LAMP1 ( Figure 5E ), suggesting that overexpressed RGS12 is endosomal.
Prolonged ERK activation by NGF is reduced upon RGS12 depletion
To explore the expression pattern of endogenous RGS12, we used subcellular fractionation following NGF stimulation of PC12 cells. Detection of RGS12 first occurs in the crude membrane fraction ( Figure 5F ; 0 min), but RGS12 subsequently is enriched in both cytosolic and nuclear fractions after NGF stimulation, with a concomitant decrease in the membrane fraction ( Figure 5F ). We observed little change in the localization or protein levels of nuclear and membrane markers (lamin A/C and pan-cadherin, respectively; McKeon et al, 1986; Takeichi et al, 1988) , suggesting that the movement of endogenous RGS12 from membrane to cytosolic and nuclear fractions is specific.
RGS12 forms a multiprotein complex containing TrkA, H-Ras, B-Raf, and MEK2
MAPK pathway scaffolds have been identified that promote formation of stable complexes containing receptors (Morrison and Davis, 2003; Kolch, 2005) . For example, b-arrestin-2 forms a complex with the angiotensin II type 1a receptor and component kinases of the ERK MAPK cascade (Luttrell et al, 2001 ). RGS12 interacts with activated H-Ras, B-Raf, and MEK2 (Figures 1, 2, and 3 ), and appears to regulate, and redistribute, upon NGF signaling in PC12 cells (Figures 4 and 5) . Thus, we hypothesized that RGS12 may also associate with the primary NGF receptor in PC12 cells: TrkA (Chao and Hempstead, 1995) . Therefore, we transiently expressed full-length RGS12 and TrkA in HEK 293T cells and assayed for protein complex formation (Figure 6 ). RGS12 co-immunoprecipitated with the TrkA receptor but not with fibroblast growth factor receptor isoforms FGFR1 ( Figure 6A ) or FGFR2 (data not shown). Coexpression of TrkA, but not FGFR1, redistributed YFP-RGS12 out of endosomes ( Figure 6B and C), suggesting that RGS12 subcellular localization is regulated specifically by TrkA. This subcellular redistribution of YFP-RGS12 appears to be dependent on TrkA kinase activity, given that kinase-inactive and kinase-domaindeleted mutants of TrkA were unable to elicit redistribution; furthermore, treatment with the TrkA inhibitor K-252a (Berg et al, 1992) blocked RGS12 redistribution by wildtype TrkA coexpression (Supplementary Figure S10) . A multiprotein complex containing RGS12, TrkA, activated H-Ras, B-Raf, and MEK2 was detected by co-immunoprecipitation ( Figure 6D ). These findings suggest that RGS12 associates with TrkA and potentially tethers the Ras-Raf-MEK signaling module to this receptor.
RGS12 receptor selectivity and role in axonal growth of primary neurons
As an interaction between RGS12 and FGFRs was not detected, we investigated whether RGS12 might selectively regulate NGF-mediated but not bFGF-mediated signaling in PC12 cells. bFGF can reproduce the entire spectrum of PC12 cell responses known to be elicited by NGF, including neurite outgrowth (Rydel and Greene, 1987) . Whereas RGS12 knockdown attenuated NGF-promoted neurite outgrowth (Figure 4) , no significant change in neurite outgrowth was seen with bFGF ( Figure 6E ). Consistent with this result, no change in RGS12 subcellular localization was observed upon stimulation with bFGF for up to 120 min ( Figure 6F ), in contrast to the movement seen upon NGF stimulation ( Figure 5F ). These data strongly suggest that RGS12 is critical for NGF-mediated, but not bFGF-mediated, neurite outgrowth and this may be due, at least in part, to a specific interaction between RGS12 and the NGF receptor TrkA.
With our findings that RGS12 (i) forms a complex with multiple proteins involved in the NGF-stimulated MAPK signaling pathway, (ii) is critical for MAPK cascade-promoted neuritogenesis in PC12 cells, and (iii) is expressed in trigeminal and DRG neurons in the E14.5 embryonic mouse (Martin-McCaffrey et al, 2005) , we surmised that RGS12 may regulate a MAPK-mediated process in primary developing neurons. The Ras/Raf/ERK cascade is known to mediate axon elongation in NGF-containing embryonic DRG cultures (Liu and Snider, 2001; Markus et al, 2002 ; see also Atwal et al, 2000) . Expression of Ras and Raf dominant inhibitory constructs strongly reduces NGF-induced axon growth from dissociated cultures of embryonic DRG neurons, and overexpression of activated H-Ras, Raf-1, or ERK leads to axonal growth comparable to that elicited by NGF treatment (Markus et al, 2002) . Here, we found that siRNA knockdown of mouse RGS12 ( Figure 7A ) leads to a significant reduction in NGF-stimulated axonal growth in E14 DRG cultures from both wild-type and Bax-null mice ( Figure 7B-D) . Experiments were performed with Bax-null as well as wildtype mice to exclude any effects of RGS12 inhibition on neuronal survival.
Discussion
The Raf-MEK-ERK cascade is often depicted as a linear signaling pathway traversing cytoplasm to connect receptor Prolonged ERK activation by NGF is reduced upon RGS12 depletion, expressed RGS12 is punctate and co-incident with endosomal markers, and translocation of endogenous RGS12 from membranes is regulated by NGF. (A) PC12 cells were transfected with non-specific or RGS12 siRNA and stimulated with NGF. ERK activation (pERK) and total ERK expression was determined by immunoblots (inset) with antiphospho-ERK1/2 or anti-ERK1/2 at indicated times after NGF treatment. Scion Image was used for densitometric quantitation of pERK1/2 levels and normalization to maximum signal (non-specific siRNA at 5 min). Error bars represent standard error of the mean from three independent experiments. (B) Prolonged ERK activation is also reduced by siRNA-mediated knockdown of B-Raf and MEK2 levels, but not A-Raf levels, in PC12 cells. Densitometric quantitation of pERK1/2 levels was normalized to maximum signal (non-specific (ns) siRNA at 120 min). (C) PC12 cells were transfected with pEYFP-N1 empty vector, YFP-RGS12, or RGS12-YFP vectors for 24 h, and treated with 100 ng/ml NGF for an additional 48 h before epifluorescence imaging. (D, E) PC12 cells were transfected with RGS12-YFP (green) for 24 h, treated with 100 ng/ml NGF for an additional 48 h, fixed, permeabilized, and stained with early endosomal marker EEA1 (D, red) or late endosomal marker LAMP1 (E, red) before confocal microscopy. Colocalization of RGS12-YFP and endosomal markers is shown in yellow. White arrows indicate colocalization of RGS12-YFP with EEA1 or LAMP1 on individual puncta. (F) PC12 cells were stimulated with NGF at indicated time points, then fractionated into membrane, cytosolic, nuclear, and cytoskeletal fractions as described in Materials and methods. Proteins resolved by SDS-PAGE were immunoblotted with anti-RGS12, or antibodies against nuclear envelope marker lamin A/C or plasma membrane marker anti-pancadherin.
well-characterized ERK scaffold, kinase suppressor of Ras (KSR), binds c-Raf-1, MEK1/2, ERK1/2, and other proteins (Kolch, 2005) , and is thought to be critical to Ras function, given that KSR1-deficient fibroblasts are impaired in both Ras-mediated ERK activation and cell transformation (Kortum and Lewis, 2004) . Our data suggest that RGS12, analogous to these established functions of Ste5 and KSR, sustains NGF-mediated ERK activation in PC12 cells and Lysates were immunoprecipitated with beads alone or anti-FLAG antibody. Anti-HA and anti-myc were used to detect associated myc-RGS12, HA-B-Raf, HA-MEK2, and HA-H-Ras G12V. (E) PC12 cells were transfected with non-specific or RGS12 siRNA for 24 h and treated with 100 ng/ml bFGF for an additional 48 h. Differences in neurite length were quantitated as described in Figure 4C . Median neurite lengths of non-specific siRNA-transfected cells were not significantly different from those of RGS12 siRNA-transfected cells (P40.03; Mann-Whitney test). (F) PC12 cells were stimulated with bFGF for the indicated durations. Cells were then fractionated into membrane, cytosolic, nuclear, and cytoskeletal fractions as in Figure 5F . Proteins resolved by SDS-PAGE were immunoblotted with anti-RGS12, or antibodies against nuclear envelope marker lamin A/C or plasma membrane marker anti-pan-cadherin.
primary neurons by forming a signaling complex containing TrkA, H-Ras, B-Raf, MEK2, and ERK proteins. MAPK scaffolds not only tether proteins together, but also specify their subcellular localization and guide their ultimate output. In tethering Ste11, Ste7, and Fus3 through independent binding sites (Choi et al, 1994) , Ste5 recruits these kinases to the plasma membrane-the site at which upstream proteins participate in pheromone-dependent activation of the MAPK cascade (Pryciak and Huntress, 1998) . In this way, Ste5 not only increases MAPK signaling efficiency, but also generates specificity by insulating the pheromone response from other parallel pathways (nutritional cues and osmotic stress), which use some or all of these same signaling components (Elion, 2001) . The ubiquity of these signaling components is even more dramatic in mammalian cells, as underscored by the fact that over 160 substrates for the finaltier kinases ERK1/2 have now been described. The majority of these ERK substrates are nuclear; however, numerous others exist in the cytosol and at other organelles, including endosomes (Roux and Blenis, 2004; Yoon and Seger, 2006) . Scaffold-mediated regulation of the utilization of particular MAPK substrates contributes to the distinct, and at times opposing, cellular events regulated by the ubiquitous MAPK cascade. In this context, our results provide several lines of evidence that RGS12 is a selective scaffold regulating prolonged ERK activation downstream of particular inputs and components: for example, NGF versus bFGF, activated H-Ras versus related GTPases, and B-Raf versus c-Raf-1.
In contrast to its robust association with activated H-Ras, RGS12 did not bind appreciably to other Ras isoforms. As H-, N-, and K-Ras are highly homologous, it is likely that their unique hypervariable linker domain sequences and differential post-translational modifications, known to sequester these Ras family members to distinct cellular locales (Ashery et al, 2006) , may dictate, in part, the functional differences seen among Ras isoforms for RGS12 association. Ras signaling from internal membrane compartments is well documented, with one well-described mechanism involving endocytosis (Jiang and Sorkin, 2002) , whereby EGF promotes internalization of active H-Ras, EGFR, and Ras effectors into endosomes. Similarly, the scaffold protein MP1, which binds to MEK1 and enhances ERK1 activation, localizes EGF-promoted Ras/MAPK signaling to late endosomes (Teis et al, 2002) ; MP1 is dispensable for transient EGFR activation of ERK at the plasma membrane, but essential for delayed activation of ERK on late endosomes. The enhancement of MAPK activation by MP1 is strictly dependent on the endosomal localization of the complex, as the artificial mislocalization of MP1 to the plasma membrane abolishes its positive effect. Thus, compartmentalizing Ras at endosomes appears to provide a means for trafficking and promoting MAPK signaling. These results, and our findings that RGS12 localizes to endocytic vesicles and binds multiple MAPK cascade components in addition to activated H-Ras, suggest that RGS12 may be a novel endosomal Ras effector scaffold.
In PC12 cells, transient ERK activation promotes cell proliferation, whereas prolonged ERK activation promotes neuronal differentiation (Heasley and Johnson, 1992; Traverse et al, 1992; Nguyen et al, 1993; Marshall, 1995) . Furthermore, endosomal localization of MAPK signaling components appears to be critical for these differences, suggesting that endosomes may serve as the sites that generate persistent, rather than transient, signaling through Ras. Here, we show that RGS12 localizes to endosomes and its depletion attenuates prolonged ERK activation and neuronal differentiation. Proteins involved in NGF-mediated neurite outgrowth are known to localize to endosomes, and this localization is critical for their participation in neuronal differentiation of PC12 cells (Zhang et al, 2000; Howe et al, 2001) . Isolated clathrin-coated vesicles from NGF-treated PC12 cells were found to contain NGF bound to TrkA together with activated signaling proteins of the Ras/MAPK pathway . Additionally, neuronal differentiation is stimulated by catalytically active Trk receptors specifically trafficked to endocytic vesicles; if NGF internalization in PC12 cells is inhibited by dominant-negative dynamin, neurite outgrowth is blunted (Zhang et al, 2000) . These results suggest that RGS12, by binding TrkA and components of the Ras/MAPK cascade, might serve to coordinate this endosomal MAPK signaling required for prolonged ERK activation and neuritogenesis.
The most compelling context for this new data regarding RGS12 as a putative endosomal scaffold for TrkA-activated MAPK signaling is in the known response of primary neurons to trophic factors. NGF signals through TrkA to promote differentiation, survival, and maintenance of primary neurons (Casaccia-Bonnefil et al, 1999; Sofroniew et al, 2001) . For neurotrophins to induce these pleiotropic effects, the signal must be communicated from axon terminals to cell bodies. One hypothesis suggests that 'signaling endosomes' containing NGF-bound TrkA are formed at the axon terminal and traffic in a retrograde manner to the cell body, where they initiate local signal transduction cascades (Howe and Mobley, 2004) ; such retrograde transport and signaling of neurotrophins like NGF is thought to be critical to the development and maintenance of the nervous system (Sofroniew et al, 2001) . NGF-containing vesicles transported retrogradely contain active components of the ERK pathway in vivo (Johanson et al, 1995) . Thus, it is possible that RGS12 represents a key component of the NGF-derived signaling endosome.
In addition to their originally described roles as Ga GAPs and negative regulators of GPCR signaling, RGS proteins increasingly appear as scaffolds that integrate signaling from diverse receptors and steer pathway output to divergent cytoplasmic signaling networks (Siderovski and Willard, 2005) . Our observation that RGS12 preferentially binds to activated H-Ras is in line with yeast two-hybrid data that Loco (the fly ortholog) interacts with Drosophila Ras1 (Formstecher et al, 2005) , suggesting that RGS12 might constitute an evolutionarily conserved molecular link that integrates receptor tyrosine kinase signaling with GPCR signaling in both vertebrates and invertebrates. Interestingly, Loco localization in surface glia is punctate throughout the cytosol , similar to RGS12 in PC12 cells, HEK 293T cells, primary airway smooth muscle cells, and primary DRG neurons (this report, Sambi et al, 2006, and unpublished results) . Although the mechanism by which RGS12 localizes to endosomes is unknown, it is possible that the Ga i -binding C-terminal GoLoco motif plays a role; we have previously reported that a loss-of-function mutation in the GoLoco motif mislocalizes RGS12 to the nucleus (Sambi et al, 2006) . Thus, the multiple functional domains within RGS12 may cooperate to define the spatial and temporal nature of an RGS12-coordinated signaling output initiated from receptor tyrosine kinases and both monomeric and heterotrimeric G-protein subunits. Our observation that reducing RGS12 expression is able to blunt the actions of oncogenic alleles of H-Ras and B-Raf highlights the importance of future investigations into RGS12 functions in transformation-promoting MAPK signal transduction beyond that of NGF-mediated axonal growth.
Materials and methods
Biological reagents and cellular assays
A list of plasmids, antibodies, agonists, and other biological materials used, as well as routine procedures for cell culturing, transient transfection of plasmid DNA, cell imaging by confocal microscopy, harvesting of cell lysates, subcellular fractionation, immunoprecipitation, and immunoblotting are described in the Supplementary data. siRNA transfection siRNAs against rat A-Raf, B-Raf, MEK2, and RGS12 (the latter including SMARTpool and constituent individual duplexes) were from Dharmacon (Lafayette, CO). Non-specific siRNA (5 0 -CUAC-GUCCAGGAGCGCACC-3 0 ) was used as a negative control (Gullapalli et al, 2006) . PC12 cells were plated the day before transfection at 130 000 or 260 000 per well in 12-well culture dishes coated with poly-D-lysine (BD Biocoat, Franklin Lakes, NJ) and transfected with 150 nM siRNA using Lipofectamine 2000 (L2K; Invitrogen) according to the manufacturer's protocol. N1E-115 cells were plated the day before transfection at 50 000 cells per well in a 12-well culture dish and transfected using L2K with 150 nM mouse RGS12 SMARTpool siRNA (Dharmacon).
PC12 differentiation
PC12 cells were transfected with non-specific or RGS12 siRNA for 24 h and treated with 100 ng/ml NGF or bFGF (in 1% serum) for an additional 48 h. Brightfield images were obtained using an Olympus IX70 with a Q-Fire CCD camera. To quantitate differences in neurite length, 4100 cells were counted per condition in three independent experiments using the ImageJ Measure feature (http://rsb.info.-nih.gov/ij/); length was converted into micrometer and analyzed for statistical significance using Prism 4.0 (GraphPad, San Diego, CA).
Transfection and imaging of primary neurons
Isolation, culture, transfection, and imaging of wild-type and Baxnull mouse embryonic DRG (embryonic day 14) were performed as described (Kim et al, 2006) , with the following modifications: DRG neuron cultures were coelectroporated with siRNA and YFP tracer DNA (pCS2-Venus; 3 mg) and subsequently stained with GFP antibody (A11122; Invitrogen) to highlight axon morphology. Quantitative determinations of axon length were based on analyses of 4100 transfected neurons each in the non-specific and RGS12 siRNA-transfected cultures.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
